Links Explored Between Antidiabetic Meds, Multiple Sclerosis Risk
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — For patients with type 2 diabetes (T2D), exposure to antihyperglycemic medications (A-HgMs) is associated with a decreased risk for developing multiple sclerosis (MS) in those who are younger than 45 years a…
Learn MoreContact Tracing Shows No Transmission From Index Monkeypox Case
TUESDAY, Nov. 8, 2022 (HealthDay News) — No secondary cases were observed in a large contact investigation in response to the first case of monkeypox virus (MPXV) infection in the United States. Results of the investigation were published online Nov….
Learn MoreOverall Cancer Mortality 18 Percent Higher in AI/AN Versus Whites
TUESDAY, Nov. 8, 2022 (HealthDay News) — Overall cancer rates are 2 percent higher and cancer mortality is 18 percent higher for American Indian and Alaska Native (AIAN) individuals compared with White individuals, according to a report published onl…
Learn MoreE-Cigarette Use Gaining in Intensity Among U.S. Teens
TUESDAY, Nov. 8, 2022 (HealthDay News) — There is increasing intensity of use of electronic cigarettes among U.S. teens, according to a study published online Nov. 7 in JAMA Network Open.Stanton Glantz, Ph.D. (retired), from San Francisco, and collea…
Learn MoreUltraprocessed Foods Tied to Premature Death
TUESDAY, Nov. 8, 2022 (HealthDay News) — Consumption of ultraprocessed foods is a significant cause of premature death, according to a study published online Nov. 7 in the American Journal of Preventive Medicine.Eduardo A.F. Nilson, Sc.D., from Unive…
Learn MoreWillingness to Use Videohealth Increased During Pandemic
TUESDAY, Nov. 8, 2022 (HealthDay News) — During the COVID-19 pandemic, there was an increase in willingness to use video telehealth, according to a report published in the November issue of Health Affairs.Shira H. Fischer, M.D., Ph.D., from the RAND …
Learn MoreAHA: Strategies Compared for Treating Chronic Limb-Threatening Ischemia
TUESDAY, Nov. 8, 2022 (HealthDay News) — For patients with chronic limb-threatening ischemia (CLTI), an initial strategy of surgical revascularization is better than endovascular therapy for those with a single segment of great saphenous vein that co…
Learn MoreAHA: Baxdrostat Studied in Treatment-Resistant Hypertension
TUESDAY, Nov. 8, 2022 (HealthDay News) — Patients with treatment-resistant hypertension who receive baxdrostat versus placebo have dose-dependent reductions in systolic blood pressure at 12 weeks, according to a study published online Nov. 7 in the N…
Learn MoreAHA: Lowering TGs With Pemafibrate Does Not Cut CV Risk in T2DM
TUESDAY, Nov. 8, 2022 (HealthDay News) — For patients with type 2 diabetes, hypertriglyceridemia, and low high-density lipoprotein cholesterol levels, the incidence of cardiovascular events is not lower with pemafibrate versus placebo, according to a…
Learn MoreMany U.S. Adults Unlikely to Enroll in Drug Trials for Dementia Prevention
TUESDAY, Nov. 8, 2022 (HealthDay News) — Just over one in 10 adults aged 50 to 64 say they are very likely to participate in a dementia drug prevention trial, according to a study published online Oct. 19 in the Journal of Prevention of Alzheimer’s D…
Learn More